Novel Coronavirus 2019 (COVID-19): Analysis of the Emerging Disease Landscape - June 2020 Update - ResearchAndMarkets.com

·3-min read

The "Coronavirus Disease 2019 (COVID-19) - Analysis of the Emerging Disease Landscape - June 2020" report has been added to ResearchAndMarkets.com's offering.

The Epidemiology of COVID-19 is rapidly evolving and a number of companies have begun to invest in this space. The absence of proven therapeutic options and the lack of a vaccine to protect against infection has led to a race to develop effective interventions. A range of players - from pharma and biotech firms to academic institutions and government agencies - have thrown their hats in the ring.

Report Scope

  • Global epidemiology metrics and trends

  • Snapshot of epidemiological trends to date in the top three most-affected countries

  • An overview of the pipeline for antivirals and vaccines

  • Summary of available efficacy data

  • An assessment of the clinical trials landscape by phase, sponsor type, geography, and other key attributes

  • Highlights in deal-making trends, particularly public-private partnerships

  • Spotlight on social media coverage

Reasons to Buy

  • Understand the global epidemiology of COVID-19

  • Obtain a snapshot of epidemiological trends to date in the top three most-affected countries

  • Access an overview of the pipeline for therapeutics and vaccines

  • Stay up to date on available efficacy data for pipeline-stage products

  • View the clinical trials landscape by across key attributes

  • Get up to speed on highlights in deal-making trends, particularly public-private partnerships

  • Monitor top trends in social media coverage

Key Topics Covered

1 Executive Summary

2 Epidemiology

2.1 Epidemiology: Snapshot as of March 25, 2020

2.2 Epidemiology: Disease Trajectory as of March 25, 2020

2.3 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in China as of March 25, 2020

2.4 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in Italy as of March 25, 2020

2.5 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in the US as of March 25, 2020

2.6 Epidemiology Forecast: United States

3 Pipeline Overview

3.1 Pipeline Therapeutics: Breakdown by Phase

3.2 Pipeline Therapeutics: Breakdown by Molecule Type

3.3 Pipeline Therapeutics: Breakdown by Type of Developer

3.4 Pipeline Therapeutics: Clinical-Stage Candidates (Phase I - III)

3.5 Pipeline Therapeutics: Preclinical-Stage Candidates

3.6 Pipeline Therapeutics: Currently Available Data

3.7 Pipeline Vaccines: Breakdown by Phase

3.8 Pipeline Vaccines: Breakdown by Developer Type

3.9 Pipeline Vaccines: Clinical and Preclinical-Stage Candidates

4 Pipeline Overview

4.1 Pipeline Therapeutics: Breakdown by Phase

4.2 Pipeline Therapeutics: Breakdown by Molecule Type

4.3 Pipeline Therapeutics: Breakdown by Type of Developer

4.4 Pipeline Therapeutics: Clinical-Stage Candidates (Phase I - III)

4.5 Pipeline Therapeutics: Preclinical-Stage Candidates

4.6 Pipeline Therapeutics: Currently Available Data

4.7 Pipeline Vaccines: Breakdown by Phase

4.8 Pipeline Vaccines: Breakdown by Developer Type

4.9 Pipeline Vaccines: Clinical and Preclinical-Stage Candidates

5 Clinical Trials

5.1 Clinical Trials: Breakdown by Phase

5.2 Clinical Trials for Therapeutics and Vaccines

5.3 Clinical Trials: Overview by Region

5.4 Clinical Trials for Therapeutics: Leading Sponsors

5.5 Clinical Trials: Leading Industry Sponsors

5.6 Trends in Trial Design

6 Deal-making Trends

6.1 Deal-making Trends

7 Social Media Trends

7.1 Key Twitter Chatter

7.2 Top Trending Tweets include #Covid19 #Coronavirus #Patients #Flattenthecurve

8 Key Findings

For more information about this report visit https://www.researchandmarkets.com/r/87ymig

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200805005541/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Latest stories

  • Trump still faces trouble ahead – whatever the final impeachment result

    Such has been the toxic nature of the current president’s tenure, that calls for action over what has happen on his watch will continue

  • Coronavirus R rate 'could be as low as 0.6' in some parts of England

    The University of Cambridge study estimates the current daily number of new infections occurring across England is 60,200.

  • Scottish fishermen forced to sail to Denmark for their catch after Rees-Mogg's 'we’ve got our fish back' boast

    Exports of fresh fish and seafood have been hit by delays following the end of the Brexit transition period.

  • 'COVID tongue' becoming more common coronavirus symptom

    Leading scientist warns the government needs to expand the list of coronavirus symptoms so people know they're infected.

  • Exports to EU to plunge by more than one-third because of Boris Johnson’s Brexit trade deal, study warns

    Income per head is forecast to fall by 6 per cent – just 2 per cent less than under a no-deal departure

  • Coronavirus in numbers: UK death toll rises by 1,248

    Public Health England said a further 1,248 people had died within 28 days of testing positive for Covid-19 in the UK as of Thursday. The number of people in the UK to have been given a first dose of a Covid-19 vaccine as of January 13 is 2,918,252, according to Public Health England (PHE), a rise of 278,943 from the figures published on Wednesday.A total of 437,977 people have received a second dose in the UK as of January 13, a rise of 9,745 from the previous day, PHE added.

  • Melania snubs meeting Jill Biden as First Lady-to-be unveils advisors

    Melania Trump is accused of having abdicated any responsibilities associated with her official role

  • Saira Khan says she had to 'tolerate' some 'Loose Women' co-stars

    The 50-year-old left the programme at the beginning of the year.

  • UK weather: Met Office issues warnings as heavy snow and ice threaten travel disruption

    20cm of snow could fall in hardest-hit areas of Scotland

  • 'Shocking' care home Covid outbreaks at levels not seen since first peak

    Outbreaks of Covid-19 in care homes have more than trebled in a month, with levels of infections now similar to the peak of the first wave, figures show. The latest surveillance data from Public Health England (PHE) reveals that, in the week to January 14, there was the second highest weekly total since records began in April. On Thursday night, senior figures said the numbers were "shocking" and warned: "Care homes cannot be neglected again." It came as the Government closed Britain's borders to Portugal and South America amid fears over a new strain of the virus from Brazil. Ministers had pledged that all care home residents would be vaccinated by the end of this month, but The Telegraph has been told the care home rollout is taking longer than the Government had anticipated. Sources said only 100 residents could be vaccinated in the time it took to administer jabs to 1,000 people in the community. On Thursday night, PHE said more than one third of people aged over 80 in England had been vaccinated, accounting for 56 per cent of the 2,371,407 vaccinations given up to January 10. Matt Hancock, the Health Secretary, has said 25 per cent of older care home residents have received the jab, up from the previous figure of 10 per cent cited by Boris Johnson last week.

  • Brexit: Boris Johnson ‘in danger of proving he is a buffoon’, says DUP’s Paisley

    PM’s attitude to disruption feels like ‘slap on the face with a wet kipper’, says Brexit backer

  • Trump Jr wanted for questioning by DC attorney general over alleged inaugural funds abuse

    Karl Racine ‘extremely confident’ US president’s eldest son broke law

  • WandaVision opening credits tease arrival of MCU’s most terrifying villain yet

    Pause episode two at the 03:27 mark

  • Fur-wearing ‘QAnon Shaman’ appeals to Trump personally for pardon over Capitol riots

    ‘My client had heard the oft-repeated words of president Trump’, says lawyer

  • Boots £5 Friday deal: The best bargain beauty buys, from No7 to Pantene

    Available in-store and online, snap them up before they're gone

  • Boris Johnson to hold Downing Street press conference at 5pm as vaccine roll-out gathers pace

    Prime Minister Boris Johnson will hold a Downing Street briefing later this afternoon as the UK continues its battle with the Covid-19 pandemic. Number 10 said the PM will appear alongside England's chief medical officer Professor Chris Whitty and chief scientific officer Sir Patrick Vallance at 5pm. Mr Johnson this week refused to rule out even tougher lockdown restrictions as hospitals come under growing strain from rising Covid-19 cases.

  • Travellers from South America banned amid fears over new Covid variant

    Transport Secretary Grant Shapps says it is a ‘precautionary’ measure to ensure the vaccine rollout is not disrupted.

  • North Korea unveils 'world's strongest weapon' at military parade

    Wearing a giant furry hat, black leather jacket and a beaming smile, North Korean leader Kim Jong-un introduced “the world’s strongest weapon” – a new submarine-launched ballistic missile – at a nighttime parade on Thursday in Pyongyang. The display of North Korea’s military might followed a rare congress of the ruling Workers' Party, during which leader Kim denounced the United States as his country's “foremost principal enemy” and vowed to strengthen the North’s nuclear war deterrent. On Friday, the reclusive regime’s state media released 100 photos of a mass celebration of the national armory, including tanks and rocket launchers, all flanked by rows of marching soldiers, noticeably not wearing masks. Military aircraft were illuminated by LED lights as they flew overhead in formation. “They’d like us to notice that they’re getting more proficient with larger solid rocket boosters,” tweeted Ankit Panda, a North Korea expert and author of ‘Kim Jong Un and the Bomb’, as the parade unfolded in Pyongyang’s Kim Il Sung square. As the spectacle reached its climax, the military rolled out what analysts said appeared to be new variants of solid-fuel short-range ballistic missiles – which are more quickly deployed than liquid-fuelled versions - and four Pukguksong-class submarine-launched ballistic missiles (SLBMs).

  • Billionaires backed Republicans who sought to reverse US election results

    Billionaires backed Republicans who sought to reverse US election resultsGuardian analysis shows Club for Growth has spent $20m supporting 42 rightwing lawmakers who voted to invalidate Biden victory

  • Experts counter charity advice not to drink for two weeks after Covid jab

    Drinking alcohol before or after having the coronavirus vaccine is unlikely to impact the effectiveness of the jab, experts have said. It comes after Drink Aware issued guidance from its independent medical advisory panel warning people not to drink “at least two days before, and at least two weeks after” being vaccinated, “to ensure your immune system is at its best to respond to the vaccine and protect you”. The comments were made by Dr Fiona Sim in her capacity as chair of the advisory panel. She is also a Senior Clinical Adviser at NHS England and a visiting professor at the University of Bedfordshire. The Drink Aware guidance adds there is “little data” about the impact of alcohol on the effectiveness of the Covid-19 vaccine. But Dr Sim states: “Chronic heavy drinking reduces immune protection, and specifically for respiratory infections, which includes Covid-19. “For greatest benefit from the vaccine, it is prudent for you not to drink any alcohol for a few days before, and for at least two weeks after, you've been vaccinated.” But other experts have said this is not necessary and is not recommended in the labelling of the Pfizer or AstraZeneca jabs. “It wouldn’t affect the immune response to be honest,” Dr Gillies O'Bryan-Tear, of the Faculty of Pharmaceutical Medicine, said. “People who drink heavily are somewhat immunosuppressed… (but) it’s certainly not advice around vaccinations I am aware of.” He added that Drink Aware “must have scientific reasons” for issuing the advice, but added: “From my point of view I can’t see why they’ve recommended that”. “We would not deny the vaccination to alcoholics,” he said. “It'll still work, they still need to be protected.” Professor Gary McLean, of the School of Human Sciences at London Metropolitan University and a visiting professor at Imperial College London, said getting “hammered” directly after taking the vaccine wouldn’t be advised. But added “usual drinking within guidelines wouldn't be wouldn't be too negative” on a person’s immune system and is unlikely to impact the effectiveness of the Covid vaccine. It is also not recommended to avoid alcohol days before the seasonal flu jab, he added.